Rexahn Merger, Contingent Value Rights Agreement (Details) |
9 Months Ended | |||
|---|---|---|---|---|
|
Sep. 30, 2024
USD ($)
Milestone
|
Sep. 30, 2021
Milestone
|
Jun. 30, 2021
Milestone
|
Nov. 05, 2020
Right
|
|
| Contingent Value Rights Agreement [Abstract] | ||||
| Contingent value rights payment period | 15 years | |||
| Sum of cash consideration paid by a third party | 75.00% | |||
| Parent IP deal period | 10 years | |||
| Payments for CVR | $ | $ 0 | |||
| Number of milestones accrued | 0 | |||
| Number of potential milestones | 0 | 0 | ||
| Rexahn [Member] | ||||
| Contingent Value Rights Agreement [Abstract] | ||||
| Number of contingent value right received per common stock | Right | 1 | |||
| Rexahn [Member] | BioSense Global LLC [Member] | ||||
| Contingent Value Rights Agreement [Abstract] | ||||
| Percentage of payments received by Rexahn or its affiliates | 90.00% | |||
| Rexahn [Member] | Zhejiang HaiChang Biotechnology Co., Ltd [Member] | ||||
| Contingent Value Rights Agreement [Abstract] | ||||
| Percentage of payments received by Rexahn or its affiliates | 90.00% |